France-based biopharmaceutical firms Stallergenes and DBV Technologies have entered into a research and development agreement for the treatment of birch allergy. Stallergenes is specialized in the manufacturing of immunotherapy medicines ...
Amarin, a biopharmaceutical company, has announced the outcome of the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee for the use of Vascepa (icosapent ethyl) capsules in the treatment of high ...
US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...
Tags: Insulin Application, biopharmaceutical company MannKind
Biopharmaceutical firm Berg and the Icahn School of Medicine at Mount Sinai have entered into a pharmaceutical and diagnostic R&D deal to leverage the power of multi-omic biology and data analytics. The deal is intended to secure new ...
US-based development-stage biopharmaceutical firm Sorrento Therapeutics has acquired Sherrington Pharmaceuticals (Sherrington), a company that provides chronic pain treatment for end-stage cancer patients and other severe pain indications. ...
Tags: Drug, Chronic Pain Treatment
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC) and Swiss biopharmaceutical firm Debiopharm Group (Debiopharm) have signed an exclusive research collaboration to develop oral small molecules ...
Tags: Cancer Drugs, Medicine
US-based clinical stage biopharmaceutical firm Heat Biologics has filed an investigational new drug application (NDA) with the US Food and Drug Administration (FDA) for its second product candidate, HS-410, which will be evaluated in ...
Germany-based clinical stage biopharmaceutical firm CureVac has entered into collaboration and licensing agreement with Janssen Pharmaceuticals to develop a messenger RNA (mRNA)-based influenza vaccine. The deal will see CureVac ...
Tags: Influenza Vaccine, Medicine
US-based biopharmaceutical company Galena Biopharma has launched the Abstral (fentanyl) sublingual tablets in the US for the treatment of breakthrough cancer pain. The sublingual (under the tongue) fentanyl tablet has been designed for ...
Tags: Sublingual Tablets, Medicine
Biopharmaceutical company Trigemina will deliver clinical data on its drug candidate TI-001 for the treatment of chronic migraine at the ongoing 7th Annual Pain Therapeutics Summit East in Boston, Massachusetts. The presentation will ...
Tags: Migraine Drug, Medicine
CureDuchenne has launched a new drug discovery and development initiative to identify and develop a pipeline of therapies to treat Duchenne muscular dystrophy. The initiative, dubbed CureDuchenne Ventures, is based on the company's ...
World biggest biopharmaceutical company Amgen in terms of market cap declared the establishment of a Chinese R&D center, another important step taken after forming a JV with Zhejiang Beta Pharma in May 2013. Amgen Global Business ...
Tags: Health, Medicine, generic drugs
US-based biopharmaceutical company NovaRx will present the results from the Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer at the European Society for Medical Oncology (ESMO) ...
Tags: Novarx, Therapeutic Vaccine Trial
Biopharmaceutical company Soligenix has secured a contract worth $6.4m from the US Department of Health and Human Service's National Institutes of Health (NIH), for the advanced preclinical development of OrbeShield (oral beclomethasone ...
US-based biopharmaceutical firm Tracon Pharmaceuticals has started dosing in a Phase Ib clinical of TRC105 for the treatment of patients with metastatic renal cell carcinoma. The trial evaluates the combination of TRC105 and a standard ...
Tags: Tracon, Carcinoma Drug